As of October 16, 2024, Johnson & Johnson had a $395.5 billion market capitalization, putting it in the 100th percentile of companies in the Pharmaceuticals industry. Currently, Johnson & Johnson’s ...
Johnson & Johnson shares advanced Tuesday after the pharmaceutical and medical device company posted better third-quarter sales and adjusted profit than expected. Net income fell sharply due to ...
Johnson & Johnson compared CARVYKTI to standard therapies in the trial. Credit: Skorzewiak/Shutterstock. Johnson & Johnson has reported data from the Phase III CARTITUDE-4 clinical trial where ...